Last reviewed: June 20, 2026

Last updated: June 20, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injections work by activating GLP-1 receptors in the brain and pancreas, but successful therapy depends on proper injection technique and site selection. Learning where and how to inject semaglutide safely ensures steady medication delivery and minimizes bruising or discomfort. PlexusDx patients receive comprehensive injection training and support to optimize their personalized weight loss treatment.

Approved Injection Sites for Semaglutide Therapy

Semaglutide injections are administered into subcutaneous tissue—the layer of fat beneath the skin—in four main areas of the body. The abdomen, thigh, upper arm, and buttocks all have sufficient subcutaneous tissue to safely deliver the medication. Each site offers comparable absorption rates, allowing patients to choose based on comfort and accessibility.

The abdomen is the most commonly recommended injection site because the skin is usually accessible and injection technique is straightforward. Many patients find abdominal injections easiest to self-administer while standing or sitting, and the area typically has adequate subcutaneous depth for all semaglutide doses. Rotating injection sites within the abdomen—changing location by at least one inch for each injection—reduces the risk of lipohypertrophy, a thickening of fatty tissue that can develop with repeated injections in the same spot.

The thigh provides an alternative site that many patients prefer for convenience, especially when traveling or when abdominal injections become uncomfortable. The outer thigh has consistent subcutaneous depth and allows for easy self-injection while seated. Buttock and upper arm injections are also effective options, though upper arm injections may require assistance if a patient has limited shoulder flexibility or visual access.

Proper Injection Technique to Reduce Pain and Bruising

Correct injection technique significantly reduces discomfort and minimizes bruising at the injection site. Before injecting, patients should clean the skin with an alcohol wipe and allow the area to air-dry completely—injecting into wet skin can cause stinging and may reduce medication absorption. Holding the pre-filled pen or syringe at a 90-degree angle to the skin, patients should insert the needle in a swift, confident motion and then push the plunger slowly to deliver the full dose over several seconds.

After the injection, applying gentle pressure with a cotton pad for 5–10 seconds helps minimize bleeding and bruising without massaging the area, which can disrupt medication absorption. Some patients find that using a smaller needle gauge (27 or 29 gauge) reduces pain compared to larger needles, and allowing the pre-filled pen to reach room temperature before injection can also decrease injection-site discomfort. Patients should never reuse needles and should dispose of sharps in a designated sharps container following local regulations.

Skin irritation, minor redness, or small bruises at the injection site are common and typically resolve within a few days. However, if a patient experiences persistent pain, warmth, swelling, or signs of infection, they should contact their healthcare provider. PlexusDx patients receive detailed injection instruction videos and can reach support staff for technique guidance whenever needed.

Site Rotation Strategy and Lipohypertrophy Prevention

Rotating injection sites is critical to prevent lipohypertrophy and ensure consistent medication absorption week to week. Lipohypertrophy—lumpy, thickened fatty tissue—can develop when the same spot receives repeated injections and may reduce how quickly semaglutide is absorbed into the bloodstream. A systematic rotation pattern, such as dividing each injection area (abdomen, thigh, arm, buttock) into quadrants and injecting in a different quadrant each week, maintains healthy tissue and medication efficacy.

Patients should also visually inspect and palpate previous injection sites to identify any bumps, firm areas, or unusual skin changes that signal lipohypertrophy development. If a patient notices thickened tissue at a site, they should avoid injecting in that area for at least 4–6 weeks to allow the tissue to normalize. Maintaining a written or digital log of injection dates and sites helps patients stay organized and prevents accidental re-injection into recently used areas.

For patients on longer-term semaglutide therapy, systematic site rotation not only prevents lipohypertrophy but also reduces overall injection discomfort and improves the patient experience. Many patients find that rotating sites keeps them engaged with their treatment plan and helps them stay consistent with their weekly injection schedule.

When to Seek Medical Guidance for Injection Site Issues

While minor injection-site reactions—redness, mild bruising, or temporary soreness—are normal, certain symptoms warrant prompt medical attention. Patients should contact their healthcare provider if they experience increasing pain that lasts more than a few hours, signs of infection such as warmth or pus, persistent swelling that doesn't improve after 48 hours, or skin changes like deep indentation or significant lumps. These symptoms may indicate improper injection technique, infection, or lipohypertrophy that requires evaluation.

PlexusDx provides ongoing patient support and can help troubleshoot injection-site concerns, answer technique questions, and coordinate with prescribing providers if clinical evaluation is needed. Patients starting compounded semaglutide at any dose receive comprehensive written and video guidance on injection site selection and technique, ensuring they feel confident from their first injection. For personalized insights into how genetic factors may influence treatment response, patients can add the Precision Peptide Genetic Test after their first month of therapy to optimize their long-term outcomes.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I inject semaglutide in the same spot every week?

No—repeatedly injecting in the same spot increases the risk of lipohypertrophy (thickened fatty tissue) that can reduce medication absorption. Rotate injection sites systematically, spacing injections at least one inch apart within each body area (abdomen, thigh, arm, or buttock). PlexusDx recommends a structured rotation schedule to keep tissue healthy and maintain consistent drug delivery.

Does injecting semaglutide hurt?

Most patients report minimal discomfort with proper technique and appropriate needle size. Using a 27 or 29-gauge needle, allowing the pen to reach room temperature, and ensuring the skin is clean and dry all reduce pain. Technique matters more than needle size—a swift, confident injection followed by slow plunger depression typically causes less discomfort than a hesitant approach.

How much does compounded semaglutide cost at PlexusDx?

PlexusDx offers compounded semaglutide injections starting at $149 per month from licensed 503A compounding pharmacies. Your dose may need to go up as your body responds to therapy, but your price won't—flat monthly pricing applies across all dose levels. PlexusDx also serves all 50 states with no insurance requirement, and injections are HSA/FSA eligible.

What should I do if I notice redness or bruising at the injection site?

Minor redness, bruising, or soreness at the injection site is normal and typically resolves within 2–3 days. Apply gentle pressure with a clean cotton pad after injection and avoid massaging the area. If redness, swelling, or pain persists beyond 48 hours, worsens, or shows signs of infection (warmth, pus), contact your healthcare provider or PlexusDx support.

Can genetic factors affect how well semaglutide works for me?

Yes—genetic variations in GLP-1 receptor function (GLP1R rs6923761), appetite regulation (FTO rs9939609), and other metabolic pathways influence individual treatment response. PlexusDx offers the Precision Peptide Genetic Test (a $99 add-on after your first month of therapy) that analyzes 14 pathways and 49 peptides to reveal your unique genetic predispositions and optimize your personalized weight loss protocol.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves